Home Other Building Blocks 13041-60-6
13041-60-6,MFCD00454253
Catalog No.:AA000UBT

13041-60-6 | Methyl 3-methoxy-2-naphthoate

Pack Size
Purity
Availability
Price(USD)
Quantity
  
250mg
96%
in stock  
$16.00   $11.00
- +
1g
96%
in stock  
$37.00   $26.00
- +
5g
96%
in stock  
$106.00   $75.00
- +
10g
96%
in stock  
$181.00   $127.00
- +
25g
96%
in stock  
$411.00   $288.00
- +
100g
96%
in stock  
$1,142.00   $799.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA000UBT
Chemical Name:
Methyl 3-methoxy-2-naphthoate
CAS Number:
13041-60-6
Molecular Formula:
C13H12O3
Molecular Weight:
216.2326
MDL Number:
MFCD00454253
SMILES:
COC(=O)c1cc2ccccc2cc1OC
NSC Number:
167526
Properties
Properties
 
BP:
217 °C / 30mmHg  
Form:
Solid  
MP:
48-51 °C(lit.)  
Storage:
Keep in dry area;2-8℃;  

Computed Properties
 
Complexity:
252  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
16  
Hydrogen Bond Acceptor Count:
3  
Rotatable Bond Count:
3  
XLogP3:
3.3  

Downstream Synthesis Route

[1]CurrentPatentAssignee:SHENYANGPHARMACEUTICALUNIVERSITY-CN105294637,2016,ALocationinpatent:Paragraph0152-0153

[2]CurrentPatentAssignee:BAYERAG-US2003/144278,2003,A1

[3]CurrentPatentAssignee:BAYERAG-US2003/181442,2003,A1

[4]CurrentPatentAssignee:BAYERAG-US2001/11135,2001,A1

[5]CurrentPatentAssignee:BAYERAG-US2002/165394,2002,A1

[6]CurrentPatentAssignee:BAYERAG-US2004/102636,2004,A1

[7]CurrentPatentAssignee:Dumas,Jacques;Miller,Scott;Osterhout,Martin;Khire,Uday;Lowinger,TimothyB.;Riedl,Bernd;Scott,WilliamJ.;Smith,RogerA.;Wood,JillE.;Gunn,David;Rodriguez,Martha;Wang,Ming;Turner,Tiffany;Brennan,Catherine-US2008/269265,2008,A1Locationinpatent:Page/Pagecolumn10-11

[8]CurrentPatentAssignee:BAYERAG-US2003/207872,2003,A1Locationinpatent:Page/Pagecolumn7

[9]CurrentPatentAssignee:BAYERAG-EP1449834,2004,A2Locationinpatent:Page17

[10]CurrentPatentAssignee:BAYERAG-EP1042305,2005,B1Locationinpatent:Page/Pagecolumn22

[11]Motomura,Takahisa;Nakamura,Hideko;Suginome,Michinori;Murakami,Masahiro;Ito,Yoshihiko[BulletinoftheChemicalSocietyofJapan,2005,vol.78,#1,p.142-146]

[12]Cohen;Dudley[JournaloftheChemicalSociety,1910,vol.97,p.1747]

[13]Cohen;Dudley[JournaloftheChemicalSociety,1910,vol.97,p.1747]

[14]Murphy;Kung;Kung;Billings[JournalofMedicinalChemistry,1990,vol.33,#1,p.171-178]

[15]Zhao,Xiao-Jing;Li,Zi-Hao;Ding,Tong-Mei;Tian,Jin-Miao;Tu,Yong-Qiang;Wang,Ai-Fang;Xie,Yu-Yang[AngewandteChemie-InternationalEdition,2021,vol.60,#13,p.7061-7065][Angew.Chem.,2021,vol.133,#13,p.7137-7141,5]

[1]Motomura,Takahisa;Nakamura,Hideko;Suginome,Michinori;Murakami,Masahiro;Ito,Yoshihiko[BulletinoftheChemicalSocietyofJapan,2005,vol.78,#1,p.142-146]

[2]Sawyer,J.Scott;Beight,DouglasW.;Smith,EdwardC.R.;Snyder,DavidW.;Chastain,MarciaK.;Tielking,RichardL.;Hartley,LawrenceW.;Carlson,DonaldG.[JournalofMedicinalChemistry,2005,vol.48,#3,p.893-896]

[3]Newsome,WesleyJ.;Ayad,Suliman;Cordova,Jesus;Reinheimer,EricW.;Campiglia,AndresD.;Harper,JamesK.;Hanson,Kenneth;Uribe-Romo,FernandoJ.[JournaloftheAmericanChemicalSociety,2019,vol.141,#28,p.11298-11303]

[4]CurrentPatentAssignee:STATEUNIVERSITYSYSTEMOFFLORIDA-WO2019/126618,2019,A1Locationinpatent:Page/Pagecolumn42;44-45

[5]Cao,Ruiyuan;Fan,Shiyong;Li,Song;Liu,Ping;Lu,Yu;Wang,Bin;Wang,Xiaokui;Zhong,Wu[BioorganicChemistry,2020,vol.102]

[6]Wu,Kun-Chan;Lin,Yu-Shan;Yeh,Yu-Shan;Chen,Chun-Yen;Ahmed,MoawiaO.;Chou,Pi-Tai;Hon,Yung-Son[Tetrahedron,2004,vol.60,#51,p.11861-11868]

[7]Legouin,Beatrice;Gayral,Maud;Uriac,Philippe;Cupif,Jean-Francois;Levoin,Nicolas;Toupet,Loic;VanDeWeghe,Pierre[EuropeanJournalofOrganicChemistry,2010,#28,p.5503-5508]

[8]Lucas,Simon;Heim,Ralf;Negri,Matthias;Antes,Iris;Ries,Christina;Schewe,KatarzynaE.;Bisi,Alessandra;Gobbi,Silvia;Hartmann,RolfW.[JournalofMedicinalChemistry,2008,vol.51,#19,p.6138-6149]

[9]CurrentPatentAssignee:TAKEDAPHARMACEUTICALCOMPANYLIMITED-EP1460062,2004,A1Locationinpatent:Page65

[10]Yamamoto,Koji;Fukushima,Hitoshi;Yumioka,Hiroya;Nakazaki,Masao[BulletinoftheChemicalSocietyofJapan,1985,vol.58,#12,p.3633-3634]

[11]Ebnoetheretal.[HelveticaChimicaActa,1952,vol.35,p.910,926]

[12]Alvarez-Bercedo,Paula;Martin,Ruben[JournaloftheAmericanChemicalSociety,2010,vol.132,#49,p.17352-17353]

[13]Correa,Arkaitz;Leon,Thierry;Martin,Ruben[JournaloftheAmericanChemicalSociety,2014,vol.136,#3,p.1062-1069]

[1]CurrentPatentAssignee:SHENYANGPHARMACEUTICALUNIVERSITY-CN105294637,2016,ALocationinpatent:Paragraph0150-0151

[2]Legouin,Beatrice;Gayral,Maud;Uriac,Philippe;Cupif,Jean-Francois;Levoin,Nicolas;Toupet,Loic;VanDeWeghe,Pierre[EuropeanJournalofOrganicChemistry,2010,#28,p.5503-5508]

[3]Cao,Ruiyuan;Fan,Shiyong;Li,Song;Liu,Ping;Lu,Yu;Wang,Bin;Wang,Xiaokui;Zhong,Wu[BioorganicChemistry,2020,vol.102]

[4]Werner;Seybold[ChemischeBerichte,1904,vol.37,p.3659]

[5]Alvarez-Bercedo,Paula;Martin,Ruben[JournaloftheAmericanChemicalSociety,2010,vol.132,#49,p.17352-17353]

13041-60-6    75-05-8   
3-(3-methoxynaphthalen-2-yl)-3-oxopropanenitrile 

[1]Havel,Stepan;Khirsariya,Prashant;Akavaram,Naresh;Paruch,Kamil;Carbain,Benoit[JournalofOrganicChemistry,2018,vol.83,#24,p.15380-15405]

[2]Long[JournaloftheAmericanChemicalSociety,1947,vol.69,p.990,993]

[1]Sawyer,J.Scott;Beight,DouglasW.;Smith,EdwardC.R.;Snyder,DavidW.;Chastain,MarciaK.;Tielking,RichardL.;Hartley,LawrenceW.;Carlson,DonaldG.[JournalofMedicinalChemistry,2005,vol.48,#3,p.893-896]

[2]Wu,Kun-Chan;Lin,Yu-Shan;Yeh,Yu-Shan;Chen,Chun-Yen;Ahmed,MoawiaO.;Chou,Pi-Tai;Hon,Yung-Son[Tetrahedron,2004,vol.60,#51,p.11861-11868]

[3]Lucas,Simon;Heim,Ralf;Negri,Matthias;Antes,Iris;Ries,Christina;Schewe,KatarzynaE.;Bisi,Alessandra;Gobbi,Silvia;Hartmann,RolfW.[JournalofMedicinalChemistry,2008,vol.51,#19,p.6138-6149]

[4]CurrentPatentAssignee:ZHEJIANGUNIVERSITY-CN108329232,2018,ALocationinpatent:Paragraph0087;0088

[5]Cohen;Dudley[JournaloftheChemicalSociety,1910,vol.97,p.1747]

[6]CurrentPatentAssignee:BAYERAG-US2003/181442,2003,A1

[7]CurrentPatentAssignee:BAYERAG-US2001/11135,2001,A1

[8]CurrentPatentAssignee:BAYERAG-US2002/165394,2002,A1CurrentPatentAssignee:BAYERAG-US2003/144278,2003,A1

[9]CurrentPatentAssignee:BAYERAG-US2004/102636,2004,A1

[10]CurrentPatentAssignee:Dumas,Jacques;Miller,Scott;Osterhout,Martin;Khire,Uday;Lowinger,TimothyB.;Riedl,Bernd;Scott,WilliamJ.;Smith,RogerA.;Wood,JillE.;Gunn,David;Rodriguez,Martha;Wang,Ming;Turner,Tiffany;Brennan,Catherine-US2008/269265,2008,A1Locationinpatent:Page/Pagecolumn10

[11]CurrentPatentAssignee:BAYERAG-US2003/207872,2003,A1Locationinpatent:Page/Pagecolumn6-7

[12]CurrentPatentAssignee:BAYERAG-EP1042305,2005,B1Locationinpatent:Page/Pagecolumn21

Literature

Title: Stepwise photochemical-chiral delivery in gamma-cyclodextrin-directed enantioselective photocyclodimerization of methyl 3-methoxyl-2-naphthoate in aqueous solution.

Journal: Langmuir : the ACS journal of surfaces and colloids 20100119

Title: Gamma-cyclodextrin-directed enantioselective photocyclodimerization of methyl 3-methoxyl-2-naphthoate.

Journal: The Journal of organic chemistry 20090501

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:13041-60-6 Molecular Formula|13041-60-6 MDL|13041-60-6 SMILES|13041-60-6 Methyl 3-methoxy-2-naphthoate |Organic_Building_Blocks